Published in J Med Virol on August 01, 2006
An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J (2008) 1.83
Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis. J Viral Hepat (2010) 1.13
Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure. J Gastroenterol (2010) 1.13
Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma. Biomark Cancer (2016) 0.85
Identification and characterization of genotype A and D recombinant hepatitis B virus from Indian chronic HBV isolates. World J Gastroenterol (2008) 0.85
Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach. World J Gastroenterol (2013) 0.84
Virologic characteristics of hepatitis B virus in patients infected via maternal-fetal transmission. World J Gastroenterol (2008) 0.83
Characterization of treatment-naive HIV/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern India. PLoS One (2013) 0.82
Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation. World J Gastroenterol (2014) 0.82
Clinical significance of genotypes and precore/basal core promoter mutations in HBV related chronic liver disease patients in North India. Dig Dis Sci (2009) 0.81
Associations between hepatitis B virus basal core promoter/pre-core region mutations and the risk of acute-on-chronic liver failure: a meta-analysis. Virol J (2015) 0.80
Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India. World J Gastroenterol (2013) 0.79
Association of Hepatitis B Virus Mutations of A1846T and C1913A/G With Acute-on-Chronic Liver Failure Development From Different Underlying Chronic Liver Diseases. Hepat Mon (2013) 0.79
Mutations of Basal core promoter and precore regions in hepatitis B virus genotypes B and C. Hepat Mon (2014) 0.77
Insights into human immunodeficiency virus-hepatitis B virus co-infection in India. World J Virol (2015) 0.75
Lower mutation frequency of BCP/precore regions in e antigen-negative chronic HBV-infected children instead of adults patients. PLoS One (2015) 0.75
Distribution of hepatitis B virus genotype and cancer predicting precore and basal core promoter mutations. Med J Armed Forces India (2015) 0.75
Current Scenario of Hepatitis B and Its Treatment in India. J Clin Transl Hepatol (2017) 0.75
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int (2008) 4.16
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology (2008) 3.26
Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol (2007) 2.11
Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia: report of a case. Hepatobiliary Pancreat Dis Int (2007) 1.93
Making and using inexpensive manually constructed tissue micro-array: experience of a tertiary care hospital in India. Indian J Pathol Microbiol (2009) 1.57
Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites. J Gastroenterol Hepatol (2005) 1.45
Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol (2011) 1.44
Increased number and function of endothelial progenitor cells stimulate angiogenesis by resident liver sinusoidal endothelial cells (SECs) in cirrhosis through paracrine factors. J Hepatol (2012) 1.42
Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol (2003) 1.36
Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology (2011) 1.34
Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol (2004) 1.33
Endoscopic biliary drainage for severe acute cholangitis in biliary obstruction as a result of malignant and benign diseases. J Gastroenterol Hepatol (2004) 1.32
An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am J Gastroenterol (2008) 1.27
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int (2007) 1.24
Repeated hydrocephalus in recurrent intraventricular neurocysticercosis: An uncommon presentation. J Neurosci Rural Pract (2013) 1.22
Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol (2006) 1.20
Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol (2010) 1.17
Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet (2002) 1.11
Endoscopic management of postoperative bile leaks. Hepatobiliary Pancreat Dis Int (2006) 1.10
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol (2007) 1.09
Primary isolated extramedullary plasmacytoma of colon. World J Surg Oncol (2007) 1.09
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance? J Gastroenterol Hepatol (2013) 1.08
Squamous variant of gallbladder cancer: is it different from adenocarcinoma? Am J Surg (2013) 1.08
Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease. J Gastroenterol Hepatol (2007) 1.08
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int (2008) 1.04
Endoscopic management of acute cholangitis in elderly patients. World J Gastroenterol (2006) 1.02
Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol (2004) 1.01
Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int (2008) 0.96
Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J Pathol Microbiol (2011) 0.95
Florid xanthogranulomatous cholecystitis masquerading as invasive gallbladder cancer leading to extensive surgical resection. Indian J Pathol Microbiol (2010) 0.94
Transmission of G145R mutant of HBV to an unrelated contact. J Med Virol (2005) 0.94
Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy. Mol Ther (2002) 0.94
Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol (2008) 0.91
Transient elastographic evaluation in adult subjects without overt liver disease: influence of alanine aminotransferase levels. J Gastroenterol Hepatol (2011) 0.91
Xanthogranulomatous cholecystitis: a premalignant condition? Hepatobiliary Pancreat Dis Int (2011) 0.91
Primary biliary cirrhosis in India. Hepatobiliary Pancreat Dis Int (2006) 0.91
Biliary obstruction in gall bladder cancer is not sine qua non of inoperability. Ann Surg Oncol (2007) 0.90
Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection. Clin Transl Gastroenterol (2012) 0.90
Management of acute hepatitis B and reactivation of hepatitis B. Liver Int (2013) 0.89
Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites. Liver Int (2012) 0.88
Molecular epidemiology and transmission of hepatitis B virus in close family contacts of HBV-related chronic liver disease patients. J Med Virol (2003) 0.87
Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus. J Med Virol (2002) 0.86
Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease. Gene (2011) 0.86
Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience. J Gastroenterol Hepatol (2007) 0.86
Endoscopic diagnosis, management and outcome of gastroduodenal tuberculosis. Indian J Gastroenterol (2012) 0.85
Gallbladder cancer with duodenal infiltration: is it still resectable? J Gastrointest Surg (2007) 0.85
CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C. World J Gastroenterol (2006) 0.85
Prevalence of autonomic dysfunction in cirrhotic and noncirrhotic portal hypertension. Am J Gastroenterol (2002) 0.85
Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure. Liver Int (2014) 0.85
Factors predicting advanced hepatic fibrosis in patients with postcholecystectomy bile duct strictures. Arch Surg (2004) 0.84
Overexpression of microRNA-30a inhibits hepatitis B virus X protein-induced autophagosome formation in hepatic cells. FEBS J (2015) 0.84
Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis. Dig Dis Sci (2007) 0.84
Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer. Gene (2013) 0.83
Histological spectrum of chronic hepatitis in precore mutants and wild-type hepatitis B virus infection. Trop Doct (2004) 0.83
Mass-forming xanthogranulomatous cholecystitis masquerading as gallbladder cancer. J Gastrointest Surg (2013) 0.83
Clinical and histopathological correlation of duodenal biopsy with IgA anti-tissue transglutaminase titers in children with celiac disease. Indian J Gastroenterol (2014) 0.83
Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience. J Vasc Interv Radiol (2012) 0.82
Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus. Liver Int (2008) 0.82
Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling. J Gastroenterol Hepatol (2011) 0.82
Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial. Liver Int (2013) 0.82
Eosinophilic abscesses: a new facet of hepatic visceral larva migrans. Abdom Imaging (2013) 0.81
Improved survival with the patients with variceal bleed. Int J Hepatol (2011) 0.81
Insulin resistance in chronic hepatitis B virus infection. Am J Gastroenterol (2009) 0.81
The hepatitis C virus NS5A protein and response to interferon alpha: mutational analyses in patients with chronic HCV genotype 3a infection from India. Med Microbiol Immunol (2006) 0.81
Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. J Gastroenterol Hepatol (2008) 0.81
A prospective analysis of the preoperative assessment of duodenal involvement in gallbladder cancer. HPB (Oxford) (2012) 0.80
Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients. Indian J Pathol Microbiol (2010) 0.80
Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients. Am J Gastroenterol (2005) 0.80
Interleukin-28b CC genotype predicts early treatment response and CT/TT genotypes predicts non-response in patients infected with HCV genotype 3. J Med Virol (2014) 0.80
Predictors of histological activity and fibrosis in chronic Hepatitis C infection: a study from North India. Indian J Pathol Microbiol (2010) 0.79
Co-occurrence of cytomegalovirus-induced vanishing bile duct syndrome with papillary stenosis in HIV infection. Hepatol Res (2013) 0.79
Liver regeneration during acute-on-chronic liver failure using growth factors: in vivo or ex vivo indulgence of bone marrow? Gastroenterology (2013) 0.79
Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients. Gastroenterology (2009) 0.79
Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF). Virchows Arch (2011) 0.79
Left atrial primary B cell lymphoma presenting with mitral regurgitation. J Card Surg (2012) 0.78
p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer. Saudi J Gastroenterol (2013) 0.78
Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients. Hepatol Int (2009) 0.78
Histological profile of liver disease in patients with dual hepatitis B and C virus infection. Indian J Pathol Microbiol (2003) 0.78
Efficacy of Shanvac-B recombinant DNA hepatitis B vaccine in health care workers of Northern India. Hepatobiliary Pancreat Dis Int (2010) 0.78
Hepatic coagulopathy-intricacies and challenges; a cross-sectional descriptive study of 110 patients from a superspecialty institute in North India with review of literature. Blood Coagul Fibrinolysis (2013) 0.78
Reimbursement policies in the Asia-Pacific for chronic hepatitis B. Hepatol Int (2014) 0.78
Preanalytical error occurrence rate in clinical chemistry laboratory of a public hospital in India. Clin Lab (2011) 0.78